M R7 Pill - beige round
Pill with imprint M R7 is Beige, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Mylan Pharmaceuticals Inc.
Rabeprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; GERD and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M R7
Rabeprazole Sodium Delayed-Release
- Imprint
- M R7
- Strength
- 20 mg
- Color
- Beige
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6709 (Discontinued)
- Inactive Ingredients
-
ammonia,
silicon dioxide,
croscarmellose sodium,
FD&C Blue No. 2,
FD&C Yellow No. 6,
magnesium oxide,
magnesium stearate,
mannitol,
medium-chain triglycerides,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
oleic acid,
polydextrose,
polysorbate 80,
sodium hydroxide,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
ferrosoferric oxide,
propylene glycol
Note: Inactive ingredients may vary.
Related images for "M R7"
More about rabeprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (85)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: proton pump inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.